Kidney transplantation has become a routine procedure in the treatment of patients with
kidney failure, and requires collaboration of experts from different disciplines, such as …

Late antibody‐mediated rejection (ABMR) is a cardinal cause of kidney allograft failure,
manifesting as a continuous and, in contrast with early rejection, often clinically silent …

Late antibody-mediated rejection (ABMR) is a leading cause of kidney allograft failure.
Uncontrolled studies have suggested efficacy of the proteasome inhibitor bortezomib, but no …

Donor-derived cell-free DNA (dd-cfDNA) is a noninvasive biomarker for comprehensive
monitoring of allograft injury and rejection in kidney transplantation (KTx). dd-cfDNA …

Despite the success of desensitization protocols, antibody-mediated rejection (AMR)
remains a significant contributor to renal allograft failure in patients with donor-specific …

Conventional histologic diagnosis of rejection in kidney transplants has limited repeatability
due to its inherent requirement for subjective assessment of lesions, in a rule-based system …

Background Correlation between antibody-mediated rejection (ABMR) and circulating HLA
donor-specific antibodies (HLA-DSA) is strong but imperfect in kidney transplant (KT) …

We previously reported a system for assessing rejection in kidney transplant biopsies using
microarray-based gene expression data, the Molecular Microscope® Diagnostic System …

Background Antibody-mediated rejection (AMR) represents one of the cardinal causes of
late allograft loss after kidney transplantation, and there is great need for noninvasive tools …

The classical pathway (CP) of complement may contribute to the pathogenesis of antibody-
mediated rejection (ABMR). Selective CP blockade may be a promising strategy to …